Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia as oral therapies for gastrointestinal diseases, today announced the publication of additional results from ...

PureTech Health (PRTC) noted that its founded entity, Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia ...

Biosciences' lead drug candidate, VE303, has been reported to demonstrate efficacy in preventing recurrent Clostridioides ...

Skanska has signed a contract with Texas A&M University System to construct the new Meat Science and Technology Center on their campus in College Station, Texas, USA. The contract is worth USD 91M, ...

Topline data for the ongoing Phase 3 pivotal RESTORATiVE303 study are expected in 2026 ...

* Terms and Conditions apply. Finance is subject to status. Applications must be a minimum age of 18. A guarantee may be ...

In a challenging year for biotechnology firms, PureTech Health PLC (PRTC) stock has touched a 52-week low, dipping to $16.81.

Insights and expert perspectives focused on the convergence of risk and resilience for secure network operations and business ...

It's been on sale a while, but it still manages to turn heads. We give the Citroen C4 Cactus the Two-Minute Road Test treatment|It's been on sale a while, but it still manages to turn heads. We give ...

The new Peugeot 208 comes with a choice of petrol, diesel or electric power. We compare all three at the car’s international ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Report on how AI is redefining market landscape - The global microbiomes market size is estimated to grow by USD 1.13 billion from 2024-2028, according to Technavio. The market is estimated to grow at ...